相关实验视频
Updated: Jun 19, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.4K
原发性阿尔多斯特罗尼斯的临床管理:最新情况
Gian Paolo Rossi1, Federico Bernardo Rossi2, Chiara Guarnieri1
1Internal and Emergency Medicine, Department of Medicine, DIME University of Padua, Italy (G.P.R., C.G., G.R., T.M.S.).
Hypertension (Dallas, Tex. : 1979)
|July 24, 2024
概括
原发性阿尔多斯特隆症 (PA) 是高血压的一个被忽视的原因. 早期检测和治疗,特别是单边PA,可以治愈高血压并预防心血管事件.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 原发性阿尔多斯子症 (PA) 是动脉高血压的普遍但未被确诊的次要原因.
- 动脉显著增加心血管事件的风险,包括心房动,中风和心肌梗塞.
- 早期诊断和治疗PA对于预防长期心血管并发症至关重要.
研究的目的:
- 提供关于初级阿尔多斯特主义的管理的最新信息.
- 强调需要提高人们的认识和改善PA的查策略.
- 为药物治疗和上腺静脉采样的替代策略提供建议.
主要方法:
- 审查最近的研究,包括AVIS-2研究.
- 分析了四十年的临床经验.
- 考虑PA管理的最新临床指南.
主要成果:
- 单侧血压,当通过手术治疗时,可以导致高血压治愈和预防心血管事件.
- 年轻患者和耐药高血压患者从早期PA诊断中获益最多.
- 上腺静脉采样,虽然是单方面PA识别的关键,但在技术上要求很高,并且往往无法获得.
结论:
- 实施简化PA诊断算法是必要的.
- 应制定避免上腺静脉采样的策略,用于无法使用的环境.
- 改善PA的检测和管理可以显著降低心血管疾病发病率和死亡率.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
414
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
414
Adrenal Gland Disorders
1.5K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.5K
Antihypertensive Drugs: Direct Renin Inhibitors
528
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
528
Antihypertensive Drugs: Potassium-Sparing Diuretics
495
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
495
Antihypertensive Drugs: Action of β1 Blockers
396
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
396
Hormonal Regulation
33.0K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.0K

